IP Library › Assignment 060111/0267
Patent Assignment
Reel/Frame 060111/0267

Assignment of Assignor's Interest

Recorded: 2022-06-06 Pages: 9
Assignors
PAPAIOANNOU, NIKOLAOS
Executed: 2021-12-09
TRAVINS, JEREMY MARK
Executed: 2021-07-22
Assignee
SHIRE HUMAN GENETIC THERAPIES, INC.
300 SHIRE WAY, LEXINGTON, MASSACHUSETTS, 02421
Covered Property (1)
Heteroaryl Plasma Kallikrein Inhibitors
Application: 17/831,716 →
Publication: US 2022/0298176
Related Assignments (6)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Jun 6, 2022
From: FINK, SARAH JOCELYN
To: BIODURO LLC
Reel/Frame 060111/0256 →
Assignment of Assignor's Interest Jun 6, 2022
From: ELLARD, JOHN MARK; RAE, ALASTAIR
To: CHARLES RIVER DISCOVERY RESEARCH SERVICES UK LIMITED
Reel/Frame 060111/0276 →
Assignment of Assignor's Interest Jun 6, 2022
From: CHARLES RIVER DISCOVERY RESEARCH SERVICES UK LIMITED
To: CHARLES RIVER LABORATORIES, INC.
Reel/Frame 060111/0297 →
Assignment of Assignor's Interest Jun 6, 2022
From: CHARLES RIVER LABORATORIES, INC.
To: SHIRE HUMAN GENETIC THERAPIES, INC.
Reel/Frame 060111/0310 →
Assignment of Assignor's Interest Jun 6, 2022
From: BIODURO LLC
To: SHIRE HUMAN GENETIC THERAPIES, INC.
Reel/Frame 060111/0330 →
Assignment of Assignor's Interest Jun 6, 2022
From: SHIRE HUMAN GENETIC THERAPIES, INC.
To: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Reel/Frame 060285/0748 →